A bone marrow toxicity model for 223Ra alpha-emitter radiopharmaceutical therapy

Physics in Medicine and Biology

Volumn 57, Issue 10, 2012, Pages 3207-3222

  Hobbs, Robert F ^a   Song, Hong ^a   Watchman, Christopher J ^b   Bolch, Wesley E ^c   Aksnes, Anne Kirsti ^d   Ramdahl, Thomas ^d   Flux, Glenn D ^e   Sgouros, George ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d Algeta ASA   (Norway)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORBED DOSE; BONE MARROW; CELL-SIZE; CLINICAL TRIAL; DOSE CALCULATION; HETEROGENEOUS DISTRIBUTIONS; PROSTATE CANCERS; TRABECULAR BONES;

BONE; CYTOLOGY; DOSIMETRY; GRAPHIC METHODS; SPHERES; STATISTICAL METHODS; TOXICITY;

CELLS;

RADIOPHARMACEUTICAL AGENT; RADIUM;

ALPHA RADIATION; ARTICLE; BIOLOGICAL MODEL; BONE MARROW; RADIATION DOSE; RADIATION EXPOSURE;

ALPHA PARTICLES; BONE MARROW; MODELS, BIOLOGICAL; RADIATION DOSAGE; RADIOPHARMACEUTICALS; RADIUM;

EID: 84860677986     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/57/10/3207     Document Type: Article

References (40)

1. Akabani G, Kennel S J and Zalutsky M R 2003 Microdosimetric analysis of alpha-particle-emitting targeted radiotherapeutics using histological images J. Nucl. Med. 44 792805 (Pubitemid 39655215)
2. Akabani G and Zalutsky M R 1997 Microdosimetry of astatine-211 using histological images: application to bone marrow Radiat. Res. 148 599607 (Pubitemid 27527750)
3. Aurlien E, Larsen R H, Akabani G, Olsen D R, Zalutsky M R and Bruland O S 2000 Exposure of human osteosarcoma and bone marrow cells to tumour-targeted alpha-particles and gamma-irradiation: analysis of cell survival and microdosimetry Int. J. Radiat. Biol. 76 112941 (Pubitemid 30488622)
4. Back T and Jacobsson L 2010 The alpha-camera: a quantitative digital autoradiography technique using a charge-coupled device for ex vivo high-resolution bioimaging of alpha-particles J. Nucl. Med. 51 161623
5. 131I-tositumomab J. Nucl. Med. 51 187884
6. Behr T M, Behe M and Sgouros G 2002 Correlation of red marrow radiation dosimetry with myelotoxicity: empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings Cancer Biother. Radiopharm. 17 44564
7. Bolch W E, Eckerman K F, Sgouros G and Thomas S R 2009 MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry - standardization of nomenclature J. Nucl. Med. 50 47784
8. Bolch W E et al 2007 Skeletal absorbed fractions for electrons in the adult male: considerations of a revised 50-microm definition of the bone endosteum Radiat. Prot. Dosim. 127 16973
9. Bourke V A, Watchman C J, Reith J D, Jorgensen M L, Dieudonne A and Bolch W E 2009 Spatial gradients of blood vessels and hematopoietic stem and progenitor cells within the marrow cavities of the human skeleton Blood 114 407780
10. 223Ra: adjuvant or alternative to conventional modalities? Clin. Cancer Res. 12 6250s7s (Pubitemid 44703798)
11. Chouin N et al 2009a Evidence of extranuclear cell sensitivity to alpha-particle radiation using a microdosimetric model: II. Application of the microdosimetric model to experimental results Radiat. Res. 171 66473
12. Chouin N et al 2009b Evidence of extranuclear cell sensitivity to alpha-particle radiation using a microdosimetric model: I. Presentation and validation of a microdosimetric model Radiat. Res. 171 65763
13. Georgiou K R, Foster B K and Xian C J 2010 Damage and recovery of the bone marrow microenvironment induced by cancer chemotherapy - potential regulatory role of chemokine CXCL12/receptor CXCR4 signalling Curr. Mol. Med. 10 44053
14. Gössner W 2003 Target cells in internal dosimetry Radiat. Prot. Dosim. 105 3942 (Pubitemid 37167926)
15. Henriksen G, Breistol K, Bruland O S, Fodstad O and Larsen R H 2002 Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model Cancer Res. 62 31205 (Pubitemid 34605984)
16. 89Sr in mice J. Nucl. Med. 44 2529
17. Hobbs R F et al 2011 A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy Med. Phys. 38 2892903
18. Hobbs R F et al 2010 Arterial wall dosimetry for non-Hodgkin lymphoma patients treated with radioimmunotherapy J. Nucl. Med. 51 36875
19. Hough M, Johnson P, Rajon D, Jokisch D, Lee C and Bolch W 2011 An image-based skeletal dosimetry model for the ICRP reference adult male-internal electron sources Phys. Med. Biol. 56 230946
20. ICRP 2003 Basic Anatomical and Physiological Data for Use in Radiological Protection: Reference Values ICRP Publication 89 (Oxford: Pergamon)
21. Larsson E, Meerkhan S A, Strand S E and Jonsson B A 2011 A small-scale anatomic model for testicular radiation dosimetry for radionuclides localized in the human testes J. Nucl. Med. 53 7281
22. Lewington V J et al 2010 Alpharadin: a novel, targeted approach for treatment of bone metastases from CRPC-calculated alpha-particle dosimetry compared to a favorable clinical safety profile ASCO Genitourinary Cancers Symp. (San Francisco, CA, USA,)
23. 223Ra-based alpha-particle-emitting pharmaceutical for the treatment of bone metastases in patients with cancer Curr. Opin. Investig. Drugs 10 134658
24. Loevinger R, Budinger T F and Watson E E 1991 MIRD Primer for Absorbed Dose Calculations (New York: The Society of Nuclear Medicine)
25. McDevitt M R et al 1998 Radioimmunotherapy with alpha-emitting nuclides Eur. J. Nucl. Med. 25 134151 (Pubitemid 28446064)
26. Nekolla E A, Kellerer A M, Kuse-Isingschulte M, Eder E and Spiess H 1999 Malignancies in patients treated with high doses of radium-224 Radiat. Res. 152 S37 (Suppl. 6)
27. Nilsson S et al 2007 Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study Lancet Oncol. 8 58794 (Pubitemid 46995621)
28. ODonoghue J A, Baidoo N, Deland D, Welt S, Divgi C R and Sgouros G 2002 Hematologic toxicity in radioimmunotherapy: dose-response relationships for I-131 labeled antibody therapy Cancer Biother. Radiopharm. 17 43543
29. Richardson R B 2008 Age-dependent changes in oxygen tension, radiation dose and sensitivity within normal and diseased coronary arteries: part C. Oxygen effect and its implications on high- and low-LET dose Int. J. Radiat. Biol. 84 85865
30. Rowland R E, Stehney A F and Lucas H F 1983 Dose-response relationships for radium-induced bone sarcomas Health Phys. 44 1531 (Suppl. 1)
31. Sgouros G 1993 Bone marrow dosimetry for radioimmunotherapy: theoretical considerations J. Nucl. Med. 34 68994 (Pubitemid 23115673)
32. Sgouros G et al 2010 MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy J. Nucl. Med. 51 31128
33. Sgouros G et al 2000 Red marrow dosimetry for radiolabeled antibodies that bind to marrow, bone, or blood components Med. Phys. 27 215064
34. Shah A P, Patton P W, Rajon D A and Bolch W E 2003 Adipocyte spatial distributions in bone marrow: implications for skeletal dosimetry models J. Nucl. Med. 44 77483 (Pubitemid 39655213)
35. Stabin M G, Sparks R B and Crowe E 2005 OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine J. Nucl. Med. 46 10237 (Pubitemid 43733519)
36. 239Pu Phys. Med. Biol. 22 3646 (Pubitemid 8031423)
37. Valentin J 2003 Basic Anatomical and Physiological Data for Use in Radiological Protection: Reference Values ICRP Publication 89 (Oxford: Pergamon)
38. Watchman C J et al 2007 Spatial distribution of blood vessels and CD34+ hematopoietic stem and progenitor cells within the marrow cavities of human cancellous bone J. Nucl. Med. 48 64554 (Pubitemid 47571423)
39. Watchman C J, Jokisch D W, Patton P W, Rajon D A, Sgouros G and Bolch W E 2005 Absorbed fractions for alpha-particles in tissues of trabecular bone: considerations of marrow cellularity within the ICRP reference male J. Nucl. Med. 46 117185 (Pubitemid 43741080)
40. Whitwell J R and Spiers F W 1976 Calculated beta-ray dose factors for trabecular bone Phys. Med. Biol. 21 1638